| Outgoing Relation(s) |
| α-adrenergic antagonist (CHEBI:37890) is a adrenergic antagonist (CHEBI:37887) |
| α-adrenergic antagonist (CHEBI:37890) is a α-adrenergic drug (CHEBI:48539) |
| Incoming Relation(s) |
| N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine (CHEBI:64098) has role α-adrenergic antagonist (CHEBI:37890) |
| N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine hydrochloride (CHEBI:64094) has role α-adrenergic antagonist (CHEBI:37890) |
| N-demethylmirtazapine (CHEBI:143428) has role α-adrenergic antagonist (CHEBI:37890) |
| rac-tamsulosin (CHEBI:142552) has role α-adrenergic antagonist (CHEBI:37890) |
| rac-tamsulosin hydrochloride (CHEBI:142565) has role α-adrenergic antagonist (CHEBI:37890) |
| 2-methoxyidazoxan (CHEBI:73287) has role α-adrenergic antagonist (CHEBI:37890) |
| ajmalicine (CHEBI:2524) has role α-adrenergic antagonist (CHEBI:37890) |
| alfuzosin (CHEBI:51141) has role α-adrenergic antagonist (CHEBI:37890) |
| asenapine (CHEBI:71253) has role α-adrenergic antagonist (CHEBI:37890) |
| asenapine maleate (CHEBI:71245) has role α-adrenergic antagonist (CHEBI:37890) |
| carvedilol (CHEBI:3441) has role α-adrenergic antagonist (CHEBI:37890) |
| cleistanthin A (CHEBI:3737) has role α-adrenergic antagonist (CHEBI:37890) |
| cleistanthin B (CHEBI:84407) has role α-adrenergic antagonist (CHEBI:37890) |
| clopenthixol (CHEBI:59115) has role α-adrenergic antagonist (CHEBI:37890) |
| dapiprazole (CHEBI:51066) has role α-adrenergic antagonist (CHEBI:37890) |
| desipramine (CHEBI:47781) has role α-adrenergic antagonist (CHEBI:37890) |
| dihydroergocristine mesylate (CHEBI:31490) has role α-adrenergic antagonist (CHEBI:37890) |
| doxazosin (CHEBI:4708) has role α-adrenergic antagonist (CHEBI:37890) |
| ergoloid mesylate (CHEBI:34706) has role α-adrenergic antagonist (CHEBI:37890) |
| flupenthixol (CHEBI:5121) has role α-adrenergic antagonist (CHEBI:37890) |
| idazoxan (CHEBI:5862) has role α-adrenergic antagonist (CHEBI:37890) |
| ketanserin (CHEBI:6123) has role α-adrenergic antagonist (CHEBI:37890) |
| ketanserin tartrate (CHEBI:183637) has role α-adrenergic antagonist (CHEBI:37890) |
| labetalol (CHEBI:6343) has role α-adrenergic antagonist (CHEBI:37890) |
| mianserin (CHEBI:51137) has role α-adrenergic antagonist (CHEBI:37890) |
| mirtazapine (CHEBI:6950) has role α-adrenergic antagonist (CHEBI:37890) |
| nefazodone (CHEBI:7494) has role α-adrenergic antagonist (CHEBI:37890) |
| paliperidone (CHEBI:82978) has role α-adrenergic antagonist (CHEBI:37890) |
| paliperidone palmitate (CHEBI:83807) has role α-adrenergic antagonist (CHEBI:37890) |
| phentolamine (CHEBI:8081) has role α-adrenergic antagonist (CHEBI:37890) |
| prazosin (CHEBI:8364) has role α-adrenergic antagonist (CHEBI:37890) |
| prochlorperazine (CHEBI:8435) has role α-adrenergic antagonist (CHEBI:37890) |
| quinidine (CHEBI:28593) has role α-adrenergic antagonist (CHEBI:37890) |
| risperidone (CHEBI:8871) has role α-adrenergic antagonist (CHEBI:37890) |
| roxindole (CHEBI:48558) has role α-adrenergic antagonist (CHEBI:37890) |
| sertindole (CHEBI:9122) has role α-adrenergic antagonist (CHEBI:37890) |
| setiptiline (CHEBI:135076) has role α-adrenergic antagonist (CHEBI:37890) |
| setiptiline maleate (CHEBI:176786) has role α-adrenergic antagonist (CHEBI:37890) |
| spiperone (CHEBI:9233) has role α-adrenergic antagonist (CHEBI:37890) |
| tamsulosin (CHEBI:9398) has role α-adrenergic antagonist (CHEBI:37890) |
| tamsulosin hydrochloride (CHEBI:9399) has role α-adrenergic antagonist (CHEBI:37890) |
| terazosin (CHEBI:9445) has role α-adrenergic antagonist (CHEBI:37890) |
| thioridazine (CHEBI:9566) has role α-adrenergic antagonist (CHEBI:37890) |
| tolazoline (CHEBI:28502) has role α-adrenergic antagonist (CHEBI:37890) |
| yohimbine (CHEBI:10093) has role α-adrenergic antagonist (CHEBI:37890) |
| zuclopenthixol (CHEBI:51364) has role α-adrenergic antagonist (CHEBI:37890) |
